Kuwait vs United Arab Emirates: Prevalence rate of hypertension in women aged 30-79
Kuwait
35.2
in 2019
United Arab Emirates
34.5
in 2019
Kuwait rank
124th
United Arab Emirates rank
127th
Prevalence rate of hypertension in women aged 30-79 over time
- Kuwait
- United Arab Emirates
How they compare
Kuwait currently reports 35.2 against 34.5 in United Arab Emirates, a difference of 0.7.
Across all 30 years both countries report, Kuwait has been ahead every year.
Kuwait ranks 124th and United Arab Emirates ranks 127th of 195 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kuwait | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 38.94 | 35.96 | 2.98 | Kuwait |
| 2000s | 39.48 | 35.99 | 3.49 | Kuwait |
| 2010s | 37.06 | 35.13 | 1.93 | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Kuwait or United Arab Emirates?
- Kuwait, at 35.2 against 34.5 in United Arab Emirates as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Kuwait and United Arab Emirates?
- 0.7, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and United Arab Emirates?
- 30 years are reported by both, from 1990 to 2019.
- How do Kuwait and United Arab Emirates rank globally for prevalence rate of hypertension in women aged 30-79?
- Kuwait ranks 124th and United Arab Emirates ranks 127th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.